Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1777)
|
Core Tip (1538)
|
Full Article (HTML) (14517)
|
Figures (1-3) (304)
|
Tables (1-5) (317)
|
Full Article (PDF)-1451K (1212)
|
Peer-Review Report-94K (364)
|
Answering Reviewers-72K (283)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (60)
|
Total Visits (26686)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1781)
|
Core Tip (1461)
|
Full Article (HTML) (8499)
|
Figures (1-1) (566)
|
Tables (1-3) (257)
|
Full Article (PDF)-1210K (704)
|
Peer-Review Report-98K (305)
|
Answering Reviewers-99K (252)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (17289)
|
Similar Articles (160)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1633)
|
Core Tip (1487)
|
Full Article (HTML) (9244)
|
Figures (1-4) (990)
|
Tables (1-1) (264)
|
Full Article (PDF)-1374K (1037)
|
Peer-Review Report-105K (292)
|
Answering Reviewers-58K (377)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (18908)
|
Similar Articles (6)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1479)
|
Core Tip (1457)
|
Full Article (HTML) (6830)
|
Figures (1-3) (395)
|
Full Article (PDF)-2317K (777)
|
Peer-Review Report-102K (292)
|
Answering Reviewers-250K (355)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (14670)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1269)
|
Core Tip (1167)
|
Full Article (HTML) (4678)
|
Figures (1-1) (269)
|
Tables (1-4) (274)
|
Full Article (PDF)-1455K (678)
|
Peer-Review Report-129K (177)
|
Answering Reviewers-81K (202)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (11541)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned
World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1337)
|
Core Tip (1096)
|
Full Article (HTML) (3718)
|
Figures (1-1) (305)
|
Tables (1-1) (267)
|
Full Article (PDF)-2534K (509)
|
Peer-Review Report-98K (244)
|
Answering Reviewers-19K (175)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (11299)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1649)
|
Core Tip (1279)
|
Full Article (HTML) (7937)
|
Figures (1-2) (372)
|
Tables (1-1) (225)
|
Full Article (PDF)-1376K (704)
|
Peer-Review Report-116K (381)
|
Answering Reviewers-78K (320)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (18705)
|
Similar Articles (67)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1619)
|
Core Tip (1480)
|
Full Article (HTML) (7287)
|
Figures (1-2) (247)
|
Tables (1-1) (230)
|
Full Article (PDF)-2415K (491)
|
Peer-Review Report-106K (365)
|
Answering Reviewers-72K (261)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (14943)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding
World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1459)
|
Core Tip (1342)
|
Full Article (HTML) (5247)
|
Figures (1-1) (259)
|
Full Article (PDF)-1040K (548)
|
Peer-Review Report-104K (312)
|
Answering Reviewers-60K (231)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (12663)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1512)
|
Core Tip (1559)
|
Full Article (HTML) (6601)
|
Figures (1-2) (294)
|
Tables (1-1) (228)
|
Full Article (PDF)-4747K (764)
|
Peer-Review Report-116K (329)
|
Answering Reviewers-128K (314)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (17477)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1226)
|
Core Tip (1019)
|
Full Article (HTML) (4076)
|
Tables (1-1) (260)
|
Full Article (PDF)-1054K (391)
|
Peer-Review Report-106K (269)
|
Answering Reviewers-75K (191)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (10363)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1435)
|
Core Tip (1117)
|
Full Article (HTML) (6454)
|
Tables (1-2) (259)
|
Full Article (PDF)-872K (621)
|
Peer-Review Report-82K (292)
|
Answering Reviewers-100K (251)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (14661)
|
Similar Articles (29)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1246)
|
Core Tip (1006)
|
Full Article (HTML) (2325)
|
Figures (1-2) (208)
|
Tables (1-1) (218)
|
Full Article (PDF)-1053K (344)
|
Peer-Review Report-98K (312)
|
Answering Reviewers-31K (175)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (11350)
|
Similar Articles (740)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1420)
|
Core Tip (1267)
|
Full Article (HTML) (6576)
|
Tables (1-4) (290)
|
Full Article (PDF)-1067K (572)
|
Peer-Review Report-118K (283)
|
Answering Reviewers-113K (298)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (14254)
|
Similar Articles (75)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1457)
|
Core Tip (1177)
|
Full Article (HTML) (8720)
|
Figures (1-1) (249)
|
Tables (1-2) (387)
|
Full Article (PDF)-1014K (447)
|
Peer-Review Report-80K (273)
|
Answering Reviewers-67K (214)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (16615)
|
Similar Articles (216)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open